Lunchtime ASX small cap wrap: Who’s hitting the panic button today?

Link copied to
clipboard

For those partial to the online dating game, Tinder is introducing a new feature: the panic button.

From next week, users in the US will be able to use the new function, which automatically alerts authorities if things start to get creepy.

Access will be granted through a separate app — Noonlight — that Tinder recently made an investment in.

And speaking of panic, we’d be remiss if we didn’t send you into the weekend with an update on China’s coronavirus outbreak.

Chinese health authorities say the number of reported cases has now reached 830, with 25 deaths. Along with the epicentre city of Wuhan, two other large cities — Huanggang and Ezhou — have now been placed into lockdown.

The potential spread of the virus has now reached Sydney, with reports that a person has been placed into quarantine at an unknown hospital for further testing.

On that bright note we turn to markets, and the ASX200 shrugged off any concerns about a global health threat as it climbed to 7,110 points into midday trade, a gain of 0.31 per cent. The Small Ords index was 0.15 per cent higher at 3,059.70 points.

WINNERS

Here are the best performing ASX small cap stocks at 12pm Friday January 24:

Swipe or scroll to reveal the full table. Click headings to sort.

Imricor Medical Systems Inc (ASX:IMR)

The biotech company held its gains into midday trade, after getting CE Mark approval from European regulators for its catheter ablation technology — a process to stop abnormal electrical pathways in the heart tissue. The approval will allow Imricor to sell its products to registered clinics across the European Union.

LOSERS

Here are the worst performing ASX small cap stocks at 12pm Friday January 24:

Swipe or scroll to reveal the full table. Click headings to sort.

Etherstack (ASX:ESK)

Shares in Etherstack slumped sharply after the company released its 4C filing for the December quarter. While it came without comment, the numbers showed that the company only has $US931,000 ($1.36m) in cash but estimates $US1.4m ($2.05m) in outflows next quarter.

The company announced a $520,000 order from Ergon Energy to the market just three minutes later but it failed to prevent the stock falling.

share

• 
• 
• 
• 

Link copied to
clipboard

SUBSCRIBE

Get the latest Stockhead news delivered free to your inbox.

Name*

Email*

Hidden

Email Lists

Morning Update

Lunch Update

Market Close Update

Weekend Update

It's free. Unsubscribe whenever you want.

By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.

You might be interested in

Health & Biotech

ScoPo’s Powerplays: Nowhere to hide as ASX health stocks tumble in broader selloff

April 19, 2024 | Nadine McGrath

Health & Biotech

ASX Health Stocks: GTG to establish pilot program in US using its geneType Breast Cancer Risk Test

April 11, 2024 | Eddy Sunarto

Health & Biotech

‘Overnight success story 18 years in the making’ – Imricor to transform cardiac ablation market

April 4, 2024 | Nadine McGrath